![John Ketchum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 459 116 $ al 30/06/2026
John Ketchum is currently Chairman at Ernest Pharmaceuticals, Llc since 2022 and Independent Director at Tango Therapeutics, Inc. since 2023.
Formerly, Mr. Ketchum was Senior VP & Region Head-Emerging Growth Market at Novartis Oncology, Inc. from 2014 to 2017.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from The University of North Carolina at Chapel Hill.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC. 0,01 % | 05/06/2026 | 14.687 ( 0,01 % ) | 459 116 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Director/Miembro de la Junta | 29/08/2023 |
Ernest Pharmaceuticals, Lcc | Presidente | 01/12/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/03/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Hamilton College (New York)
 Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Ernest Pharmaceuticals, Lcc |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
